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ABSTRACT 
TWE-PRIL is a naturally-occurring fusion protein of components of two TNF 
superfamily members: the extracellular domain of APRIL and the intracellular and 
transmembrane domains of TWEAK with no known function. Here we show that April-/- 
mice (which lack APRIL and TWE-PRIL) exhibited overgrowth of sympathetic fibers in 
vivo, and sympathetic neurons cultured from these mice had significantly longer axons than 
neurons cultured from wild type littermates. Enhanced axon growth from sympathetic 
neurons cultured from April-/- mice was prevented by expressing full-length TWE-PRIL in 
these neurons but not by treating them with soluble APRIL.  Soluble APRIL, however, 
enhanced axon growth from the sympathetic neurons of wild type mice.  siRNA knockdown 
of TWE-PRIL but not siRNA knockdown of APRIL alone also enhanced axon growth from 
wild type sympathetic neurons. Our work reveals the first and physiologically relevant role 
for TWE-PRIL and suggests that it mediates reverse signaling. 
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INTRODUCTION 
Key to understanding how functional neural circuits are established in development 
is the identification and characterization of the signals that regulate the growth, branching 
and disposition of neural processes.  A great deal has been learned about the nature of these 
signals and how they operate by studying neurons of the vertebrate peripheral nervous 
system (PNS), not least because of the ease with which PNS neurons can be cultured and the 
ease with which the innervation of various tissues can be studied in vivo.  Pre-eminent 
among the signals that regulate the growth of neural processes is the nerve growth factor 
(NGF) family of neurotrophins (Huang and Reichardt, 2001).  These secreted proteins are 
generally synthesized in the periphery by innervated tissues and have two main functions in 
PNS neuron development: they promote neuron survival and stimulate the growth and 
branching of axons within innervated tissues.  As such, they play a key role in regulating 
neuron number and tissue innervation (Davies, 2003; Glebova and Ginty, 2004).  
In addition to neurotrophins and other neurotrophic factors, members of the tumour 
necrosis factor superfamily (TNFSF) have recently been recognized to be physiologically 
relevant regulators of axon growth during development. The 19 members of this superfamily 
are best understood for their many critical functions in the development and function of the 
immune system, but are increasingly recognized as having diverse roles in other tissues and 
organs (Hehlgans and Pfeffer, 2005). Several TNFSF members have been shown to 
modulate axon growth, generally without affecting neuronal survival.  For example, in 
certain populations of neurons, GITRL (TNFSF18) and APRIL (a proliferating-inducing 
ligand, TNFSF13) enhance axon growth (McWilliams et al., 2017; O'Keeffe et al., 2008; 
Osorio et al., 2014), whereas RANKL (TNFSF11) and LIGHT (TNFSF14) suppress the 
axon growth-promoting actions of neurotrophins (Gavalda et al., 2009; Gutierrez et al., 
2013). Members of the TNFSF are type II transmembrane glycoproteins that are active both 
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as membrane-integrated ligands and as soluble ligands after cleavage from the cell 
membrane.  They exert their effects by binding to members of the tumour necrosis factor 
receptor superfamily (TNFRSF) (Hehlgans and Pfeffer, 2005).  In addition to functioning as 
ligands, several membrane-integrated TNFSF members can act as reverse signaling 
receptors for their respective TNFRSF partners, which function as activating ligands (Sun 
and Fink, 2007).  Recently, TNFSF reverse signaling has been shown to be physiologically 
relevant for the regulation of axon growth and tissue innervation in the developing PNS.  
For example, TNFR1-activated TNF reverse signaling (Kisiswa et al., 2013, 2017; Wheeler 
et al., 2014) and CD40-activated CD40L reverse signaling (McWilliams et al., 2015) 
enhance axon growth and promote the innervation of certain tissues in vivo.  CD40-activated 
CD40L reverse signaling also enhances the growth and branching of excitatory neuron 
dendrites and suppresses the growth and branching of inhibitory neuron dendrites in the 
developing CNS (Carriba and Davies, 2017).  
APRIL is best characterized for its role in regulating lymphocyte survival and 
activation (Schneider, 2005).  In the developing nervous system, soluble APRIL enhances 
axon growth from cultured hippocampal pyramidal neurons and midbrain dopaminergic 
neurons, and in vivo studies have revealed that the initial nigrostriatal projection is 
significantly compromised in April-/- embryos (McWilliams et al, 2017; Osorio et al, 2014). 
The April gene is adjacent to the gene that encodes another member of the TNFSF, TWEAK 
(TNF-like weak inducer of apoptosis, TNFSF12).  A differentially spliced hybrid transcript 
is translated into a protein, TWE-PRIL, that comprises the extracellular domain of APRIL 
and the cytoplasmic and transmembrane domains of TWEAK (Kolfschoten et al., 2003; 
Pradet-Balade et al., 2002).  While T-cells and monocytes express TWE-PRIL and the 
protein has been shown to stimulate cycling lymphoma cell lines (Pradet-Balade et al., 
2002), no biological function has yet been ascribed to this protein in vivo.   
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The sympathetic neurons of the rodent superior cervical ganglion (SCG) comprise 
one of the most extensively studied populations of neurons in the developing PNS.  These 
neurons innervate cranial tissues and become dependent on NGF for survival shortly after 
their axons reach and ramify within their target tissues (Davies, 2009; Glebova and Ginty, 
2005).  Our current in vivo and in vitro studies of SCG neurons of April-/- mice (which lack 
APRIL and TWE-PRIL) together with siRNA transfection in wild type neurons to 
selectively knock down expression of particular proteins have revealed the first 
physiologically relevant role for TWE-PRIL. This functions as a suppressor of NGF-
promoted sympathetic axon growth and accomplishes this role via a novel signaling 
mechanism; TWE-PRIL-mediated reverse signaling activated by one of the canonical 
APRIL receptors, BCMA (TNFRSF17), functioning as the ligand. 
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RESULTS 
Expression of APRIL, TWEAK, TWE-PRIL and BCMA in SCG neurons 
To begin to examine whether TWE-PRIL and/or APRIL play a role in developing 
sympathetic neurons, we used RT-qPCR to assess the expression of Twe-pril and April 
mRNAs in SCG dissected from mice at stages throughout embryonic and postnatal 
development.  We also measured the levels of transcripts encoding BCMA (TNFRSF17) and 
TACI (TNFRSF13B), the TNFRSF members that bind APRIL/TWE-PRIL (Bossen and 
Schneider, 2006). For completeness, we also measured the levels of Tweak mRNA in the 
developing SCG. To assess expression of Twe-pril mRNA, we used primers that bind either 
side of the junction of the regions encoding the APRIL and TWEAK components of this 
fusion protein.  The relative levels of expression of these transcripts were quantified relative 
to their levels in adult spleen.  
Twe-pril, April, Tweak and Bcma mRNAs were reliably and consistently detected in 
the developing SCG.  April and Bcma mRNAs were first detected at E13 when the SCG 
becomes anatomically discernable and the earliest axons are growing to their targets. Twe-
pril and Tweak mRNAs were first detected at E15, which is a day after the earliest axons 
reach their targets and have started to grow and branch within their targets (Fig. 1A). Taci 
mRNA was barely detectable and not accurately quantifiable at any of the embryonic and 
postnatal ages studied.  
To confirm expression of the encoded proteins, we visualized these proteins by 
immunocytochemistry in dissociated SCG cultures established from P0 mice.  TWE-PRIL 
and APRIL were localized using an antibody that recognizes an epitope in the extracellular 
domain of both TWE-PRIL and APRIL.  This antibody strongly labeled virtually all SCG 
neurons (Fig. 1B).  Labeling was not observed in cultures established from P0 April-/- mice 
(Fig. 1), confirming the specificity of this antibody.  Virtually all SCG neurons were also 
D
e
v
e
lo
p
m
e
n
t 
 
A
c
c
e
p
te
d
 m
a
n
u
sc
ri
p
t
labeled by anti-BCMA and by anti-TWEAK. Labeling with anti-TACI antibodies was barely 
above background. In double labeling experiments, the neurons were co-labeled by anti-
APRIL/TWE-PRIL and anti-BCMA. These studies suggest that SCG neurons co-express 
TWE-PRIL/APRIL and BCMA.   
 
Increased in vivo growth of sympathetic fibres in April-/- mice 
 Given the evidence that APRIL promotes the early growth of axons from at least two 
kinds of CNS neurons (McWilliams et al, 2017; Osorio et al, 2014) and our current 
demonstration that developing SCG neurons express TWE-PRIL/APRIL, we investigated 
whether absence of TWE-PRIL/APRIL affects the projection and early ramification of 
sympathetic axons in their targets by comparing the sympathetic innervation of April-/- 
embryos (which lack APRIL and TWE-PRIL) and April+/+ littermates.  Immunolabeling-
enabled three-dimensional imaging of solvent-cleared organs (iDISCO) (Renier et al, 2014) is 
particularly appropriate for examining this, as it facilitates imaging the sympathetic 
innervation of SCG targets in cleared heads at a stage of development when sympathetic 
fibers are growing and branching within their targets.  Sympathetic fibers were labeled with 
an antibody against tyrosine hydroxylase (TH), a rate-limiting enzyme of noradrenaline 
synthesis.  These studies were carried out at E16, which is 2 days after the earliest 
sympathetic fibers have reached their targets and have started to ramify in these targets, but is 
before the sympathetic innervation becomes too dense to reliably quantify with this 
technique.   
The iDISCO preparations were visualized by light sheet fluorescent microscopy at 
optical sections of 5 m (between 600 and 800 optical sections per animal, which included all 
rostrally-directed fibers from both SCG).  Individual optical sections were assembled into 
three-dimensional reconstructions of sympathetic fibers emanating from the SCG using 
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Bitplane Imaris software (Bitplane Scientific Solutions, Zurich, Switzerland), which allows 
topographic manipulation of the reconstructions for accurate fiber tracing and measurement.  
Examination of collapsed Z-stack light sheet images (Fig. 2A) and Bitplane Imaris 
reconstructions (Fig. 2B) showed that the gross anatomical disposition of individual fibres in 
whole heads of April+/+ and April-/- mice were similar at E16.  However, measurements of the 
lengths of the longest SCG fibers (which terminate in nasal tissue at this stage) in Bitplane 
Imaris reconstructions revealed significantly longer fibers in April-/- mice compared with 
April+/+ littermates (Fig. 2C).  Bitplane Imaris reconstructions facilitated semi-manual tracing 
of individual SCG fibers (Fig. 2D).  The small number of caudally-directed and short local 
SCG fibers were excluded from these tracings because the full extent of caudally-directed 
fibers could not be followed because several of these had been severed when heads were 
collected for iDISCO preparations and because of the complexity of local SCG fibers.  
Measurements taken from these manual tracings revealed a highly significant, two-fold 
increase in the combined lengths of fibers in E16 April-/- mice compared with April+/+ 
littermates (Fig. 2E). All analysis was carried out blind. Importantly, when quantification was 
carried out using a surface rendering programme that required no observer input following 
manual threshold optimization (Fig. 2F), April-/- heads still exhibited a highly significant 
increase in total sympathetic innervation compared with April+/+ littermates (Fig. 2G).  
To exclude the possibility that these results may reflect differences in the level of 
expression of TH between the SCG neurons of April+/+ and April-/- mice, we used western 
blotting to estimate the relative levels of TH in the SCG of these mice. There was no 
significant difference in TH levels between the SCG of April+/+ and April-/- mice at E16 (Fig. 
S1). In summary, our studies suggest that SCG sympathetic fibers in April-/- embryos grow 
longer than in April+/+ littermates. 
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Increased in vitro growth of axons from April-/- SCG neurons 
 To ascertain whether the long sympathetic fiber phenotype observed in April-/- 
embryos in vivo is replicated by sympathetic neurons cultured from these embryos, we 
compared the size of the axon arbors of SCG neurons cultured from April+/+ and April-/- mice.  
We established very low density dissociated cultures from E16, P0, P3 and P5 April+/+ and 
April-/- littermates in culture medium supplemented with 0.1 ng/ml NGF to stimulate axon 
growth and 25 μM of pancaspase inhibitor Boc_D_FMK to prevent apoptosis.  After 16 hours 
incubation, the neurons were labeled with the fluorescent vital dye calcein-AM, and images 
of individual neurons were acquired.  In these short-term cultures all neurites are structurally 
axons (Lein et al, 1995). Neurons cultured from April-/- mice had larger axon arbors than 
those grown from April+/+ mice, as shown by representative neurons in P0 cultures (Fig. 3A).  
These differences and how they change in development are clearly illustrated in Sholl plots, 
which provide a graphic illustration of axon length and branching with distance from the cell 
body (Sholl, 1953). The differences in axon arbor size between April-/- and April+/+ neurons 
were greatest in cultures established at E16 and P0. Differences were negligible in P3 
cultures and were not discernable in P5 cultures (Fig. 3B).     
NGF dose responses carried out at E16, P0 and P3 in the presence of the pancaspase 
inhibitor Boc_D_FMK revealed that the difference in total axon length in the neuron arbors 
between April-/- and April+/+ neurons increased with NGF concentration.  As shown in P0 
cultures, there were no differences in total axon length in the absence of NGF and the 
differences between April-/- and April+/+ neurons increased with increasing NGF concentration 
up to 10 ng/ml and (the highest concentration of NGF used) (Fig. 3C).  Very similar 
differences were observed in E16 cultures and a similar trend was observed in P3 cultures, 
although the differences were not as great (not shown).  
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 Although there were significant differences in NGF-promoted axon growth between 
the SCG neurons of April+/+ and April-/- mice, there were no significant differences in NGF-
promoted survival.  In the absence of Boc_D_FMK, overlapping NGF survival dose responses 
were obtained from SCG neurons of April+/+ and April-/- mice, as illustrated for P0 cultures 
(Figure 3D). Overlapping NGF survival dose responses were also observed in cultures of 
SCG neurons of April+/+ and April-/- littermates set up at E16 and P3 (not shown).   
In summary, these findings show that NGF-promoted axon growth, but not survival, 
is significantly greater from April-/- SCG neurons, compared with April+/+ SCG neurons.  The 
enhanced response to NGF occurs over a window of perinatal development when axons are 
ramifying in their targets under the influence of target-derived NGF.  Because SCG neurons 
cultured from April-/- mice mirror the in vivo phenotype, we were able to undertake additional 
in vitro studies to clarify the mechanism underlying this phenotype. 
 
siRNA knockdown of TWE-PRIL/APRIL, but not APRIL alone, increases sympathetic 
axon growth  
 To compliment and extend our in vitro studies of NGF-promoted axon growth from 
SCG neurons cultured from April+/+ and April-/- mice, we used siRNA to knock down 
expression of TWE-PRIL, APRIL, TWEAK, BCMA and TACI in SCG neurons cultured 
from wild type mice.  We co-transfected P0 SCG neurons with specific siRNA 
oligonucleotides together with a GFP expression vector to identify and label the transfected 
neurons.  The neurons were transfected by electroporation, after which they were plated in 
NGF-containing medium and were imaged 16 h later.  We used combinations of three 
different specific 21-mer siRNA oligonucleotides that have been individually validated by the 
manufacturer to knock down expression of the target protein in cell lines. Although it was not 
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possible to knock down TWE-PRIL without knocking down either APRIL or TWEAK, by 
using siRNAs that target the parts of April and Tweak mRNAs that do not encode part of 
TWE-PRIL it was possible to knock down either APRIL or TWEAK without affecting TWE-
PRIL expression (Fig. 4A). To control for non-specific effects of siRNA transfection, we 
transfected SCG neurons with a 21-mer double-stranded RNA oligonucleotide that has a 
scrambled sequence. 
 We used immunocytochemistry to confirm selective knockdown of these proteins in 
transfected neurons. BCMA siRNAs greatly reduced BCMA immunoreactivity, TWEAK 
siRNAs eliminated TWEAK immunoreactivity and either APRIL siRNAs or APRIL/TWE-
PRIL siRNAs eliminated APRIL/ TWE-PRIL immunoreactivity  (Fig. S2).  TWEAK siRNAs 
did not affect APRIL/ TWE-PRIL immunoreactivity and APRIL siRNAs did not affect 
TWEAK immunoreactivity (Fig. S3). 
 Neurons transfected with siRNAs that reduce expression of TWE-PRIL and APRIL 
(siRNAs that targeted sequences in exons 4 and 6 of the April gene, equivalent to exons 11 
and 13 of the Twe-pril primary transcript, Fig. 4A) had significantly longer axons than those 
of neurons transfected with control RNA oligonucleotides (Figs. 4B and 4C).  In contrast, 
neurons transfected with siRNAs that selectively knock down APRIL expression without 
affecting TWE-PRIL expression (siRNAs that targeted sequences in exon 1 of the April gene, 
Fig. 4A) had axons that were no longer than those of neurons transfected with control RNA 
oligonucleotides (Figs. 4B and 4C).  Likewise, siRNA that specifically knocked down 
expression of TWEAK without affecting TWE-PRIL expression (siRNAs that targeted 
sequences in exon 7 of the Tweak gene) had no significant effect on axon growth (Fig. 4C).  
Knocking down expression of both APRIL and TWEAK without affecting TWE-PRIL 
expression (co-transfecting neurons with the siRNAs that selectively target APRIL plus 
siRNAs that target TWEAK) also had no significant effect on axon growth.  However, co-
D
e
v
e
lo
p
m
e
n
t 
 
A
c
c
e
p
te
d
 m
a
n
u
sc
ri
p
t
transfecting neurons with the siRNAs that reduce expression of TWE-PRIL and APRIL plus 
the siRNAs that target TWEAK had had significantly longer axons than those of neurons 
transfected with control RNA oligonucleotides (Fig. 4C). Taken together, these findings 
suggest that TWE-PRIL, but neither APRIL nor TWEAK, participates in the suppression of 
NGF-promoted axon growth from cultured SCG neurons.  This in turn suggests that absence 
of TWE-PRIL, rather than absence of APRIL, underlies the in vivo sympathetic phenotype of 
April-/- embryos. 
 In accordance with differences in the expression of BCMA and TACI  (Fig. 1A), 
siRNAs that specifically targeted BCMA, but not siRNAs that targeted TACI, significantly 
increased axon growth from transfected SCG neurons (Figs. 4B and 4C).  This suggests that 
BCMA, but not TACI, participates in the suppression of NGF-promoted axon growth from 
developing SCG neurons. 
 
Rescue of the in vitro phenotype of April-/- SCG neurons by expressing TWE-PRIL 
 The above findings suggest that the interaction between TWE-PRIL and BCMA 
suppresses NGF-promoted axon growth.  However, these findings do not indicate the 
direction of signaling: either TWE-PRIL-activated BCMA-mediated forward signaling or 
BCMA-activated TWE-PRIL-mediated reverse signaling.  To distinguish between these 
alternatives, we asked whether or not soluble APRIL was sufficient to reverse the enhanced 
NGF-promoted axon growth from April-/- SCG neurons (which would be consistent with 
forward signaling) or whether expression of membrane integrated TWE-PRIL is required.   
The axon arbors of NGF-supplemented P0 April-/- SCG neurons were very similar 
with or without soluble recombinant APRIL in the culture medium (Fig. 5A). This suggests 
that soluble APRIL is unable to rescue the enhanced NGF-promoted axon growth phenotype 
of cultured April-/- SCG neurons.  In contrast, the axon arbors of NGF-supplemented P0 
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April-/- SCG neurons transfected with a full-length TWE-PRIL expression plasmid were 
significantly shorter than those of control-transfected April-/- SCG neurons (neurons 
transfected with an empty expression plasmid) and were not significantly different from 
control-transfected April+/+ SCG neurons (Figs. 5B and 5C). This suggests that expression of 
full-length TWE-PRIL completely rescued the enhanced NGF-promoted axon growth 
phenotype of April-/- SCG neurons.  These findings are consistent with the idea that TWE-
PRIL-mediated reverse signaling suppresses NGF-promoted axon growth.   
A wealth of evidence suggests that the intracellular domain of TNFSF members that 
are able to mediate reverse signaling is essential for this mode of signaling (Fink and Sun and 
Fink, 2007).  To test the importance of the intracellular domain of TWE-PRIL for reverse 
signaling, we transfected neurons with a plasmid that expresses a truncated form of TWE-
PRIL that lacks the entire intracellular domain derived from TWEAK apart from the 
initiation codon of this type II glycoprotein but retains the transmembrane domain derived 
from TWEAK and the extracellular domain derived from APRIL (TWE-PRIL). The size of 
the axon arbors of NGF-supplemented P0 April-/- SCG neurons transfected with this 
expression plasmid were not significantly different than those of control-transfected April-/- 
SCG neurons (Fig. 5C).  Expression of neither full-length TWEAK nor full-length BCMA 
were able to substitute for full-length TWE-PRIL in suppressing enhanced NGF-promoted 
axon growth from April-/- SCG neurons (Fig. 5C). 
 Interestingly, transfecting April-/- SCG neurons with a plasmid that expresses full-
length APRIL was able to prevent enhanced NGF-promoted axon growth from April-/- SCG 
neurons.  This suggests that over-expressed APRIL is able to mediate reverse signaling and is 
able to substitute for TWE-PRIL in suppressing NGF-promoted axon growth from April-/- 
SCG neurons.  
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Soluble APRIL replicates the in vitro phenotype of April-/- SCG neurons  
 While the above findings are consistent with the operation of BCMA-activated TWE-
PRIL-mediated reverse signaling, to provide an additional test that signaling occurs in this 
direction, we studied the effects of soluble recombinant APRIL on NGF-promoted axon 
growth from wild type SCG neurons.  We reasoned that soluble APRIL should compete with 
endogenous membrane integrated TWE-PRIL for binding to BCMA. This should interfere 
with endogenous BCMA-activated TWE-PRIL-mediated reverse signaling, but should not 
inhibit BCMA-mediated forward signaling.  Soluble APRIL caused a dose-dependent 
increase in NGF-promoted axon length, reaching a plateau at 100 ng/ml APRIL (Figs. 6A and 
6B).  The period of development over which soluble APRIL treatment enhanced NGF-
promoted axon growth from wild type SCG neurons was similar to the period of development 
over which SCG neurons cultured from April-/- mice displayed increased responsiveness to 
NGF.  Sholl plots of NGF-supplemented E16, P0, P3 and P5 wild type SCG neurons grown 
with and without soluble APRIL showed that the enhancement of NGF-promoted axon 
growth by APRIL was greatest in E16 and P0 cultures (Fig. 6C).  Moreover, the magnitude 
by which APRIL enhanced NGF-promoted axon growth from wild type SCG neurons was 
very similar to the magnitude of NGF-promoted axon growth from SCG neurons cultured 
from April-/- mice, compared with the magnitude of NGF-promoted axon growth from SCG 
neurons cultured from April+/+ mice (compare Figs. 3B and 6C).  The influence of soluble 
APRIL on NGF-promoted axon growth from wild type SCG neurons was also related to NGF 
concentration.  While APRIL had no effect on axon growth from SCG neurons grown with 
low levels of NGF, it progressively enhanced NGF-promoted axon growth with increasing 
NGF concentration (Fig. 6D), as is the case with SCG neurons of April-/- mice compared with 
SCG neurons of April+/+ mice. As is the case with absence of APRIL, treatment with soluble 
APRIL had no effect on NGF-promoted survival. In the absence of Boc_D_FMK, overlapping 
D
e
v
e
lo
p
m
e
n
t 
 
A
c
c
e
p
te
d
 m
a
n
u
sc
ri
p
t
NGF survival dose responses were observed from P0 SCG neurons grown with and without 
APRIL (Fig. 6E).  Taken together, the above results indicate that soluble APRIL enhances 
NGF-promoted axon growth from wild type SCG neurons, but not NGF-promoted survival, 
over the same period of development and to the same extent as a null mutation in the April 
gene.  
 
TWE-PRIL reverse signaling suppresses axonal growth by supressing ERK1/ERK2 
activation in response to NGF 
Because activation of the MEK/ERK pathway contributes to the axon growth 
response to NGF (Gomez and Cohen, 1991; Goold and Gordon-Weeks, 2005; O’Keeffe et 
al., 2008) and is an essential step in the axon growth response of sympathetic neurons to 
TNFR1-activated TNF-mediated reverse signaling (Kisiswa et al., 2017), we investigated 
whether TWE-PRIL/APRIL modulates ERK activation by NGF and whether this plays a role 
in axon growth suppression by TWE-PRIL reverse signaling.  We began by investigating 
whether the expression of TWE-PRIL/APRIL influences ERK activation by NGF. For these 
studies, we used western blotting to compare ERK activation in response to NGF in SCG 
neurons cultured at high density from April+/+ and April-/- mice. These studies revealed that 
the level of phospho-ERK1/ERK2 relative to total ERK1/ERK2 was significantly greater in 
NGF stimulated P0 SCG neurons cultured from April-/- mice compared with those cultured 
from April+/+ littermates (Figs. 7A and 7B).   
To investigate if suppression of NGF-stimulated ERK1/ERK2 activation by TWE-
PRIL reverse signaling contributes to axon growth suppression, we studied the effect of 
U0126, a selective MEK1/MEK2 inhibitor that interferes with MEK1/MEK2 dependent 
activation of ERK1/ERK2, on axon growth from SCG in which TWE-PRIL reverse signaling 
was either permitted or prevented.  In these experiments, P0 SCG neurons from April-/- and 
April+/+ mice were plated at low density in medium containing either U0126 or U0124 and 
were treated with NGF after an hour. Half of the cultures were additionally treated with 
soluble APRIL at this time to inhibit TWE-PRIL reverse signaling.  Neurons in all cultures 
were imaged 16 hours after plating. The control compound U0124 did not affect the marked 
difference in axon length between neurons cultured from April-/- and April+/+ mice. However, 
axon length in cultures established from April-/- mice was significantly reduced by U0126 to 
the level observed from April+/+ neurons cultured with U0124 (Fig. 7C).  U0126 also 
significantly reduced the enhanced axon growth of wild type neurons treated with APRIL to 
the level observed in wild type neurons that had not been treated with APRIL (Fig. 7C). 
Taken together, these findings suggest that suppression of NGF-stimulated ERK activation 
contributes to the suppression of axon growth by TWE-PRIL reverse signaling. 
We also explored the possibility that differences in the expression of NGF receptors 
might account for the differences in the activation of ERK1/ERK2 in April-/- and April+/+ SCG 
neurons by NGF.  Western blotting revealed there were no differences in the intensity of the 
bands corresponding to TrkA (the NGF receptor tyrosine kinase) in SCG neurons from April-
/- and April+/+ mice grown with different levels of NGF (Fig. 7A).  In addition, qPCR revealed 
that there were no significant differences in the levels of TrkA mRNA and p75 mRNA 
(which encodes the common neurotrophin receptor) between April-/- and April+/+ SCG (Fig. 
S4). 
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DISCUSSION 
We have shown that April null mice, which lack both APRIL and TWE-PRIL, have 
significantly longer sympathetic fibers in vivo at the stage when sympathetic axons are 
starting to ramify in their targets under the influence of target-derived NGF.  This implies that 
APRIL and/or TWE-PRIL are physiologically relevant suppressors of sympathetic fiber 
elongation in vivo. The axon arbors of sympathetic neurons cultured from April-/- mice were 
significantly larger than those of wild type littermates grown in the presence of NGF, but 
were not significantly different in the absence of NGF.  This suggests that APRIL and/or 
TWE-PRIL suppress NGF-promoted axon growth from developing sympathetic neurons.  
The difference in NGF-promoted axon growth between SCG neurons of April+/+ and April-/- 
mice was observed over a window of development from late fetal to early postnatal stages.  
Moreover, whereas the axon growth response of SCG neurons to NGF was affected by the 
April null mutation, the survival response of these neurons to NGF was completely 
unaffected.  This suggests that APRIL and/or TWE-PRIL suppress NGF-promoted axon 
growth, but not NGF-promoted neuron survival. These features echo emerging themes in the 
influence of the TNFSF on axon growth in the developing PNS.  Whereas several TNFSF and 
TNFRSF members promote or inhibit axon growth, they have no or negligible effect on 
neuron survival (Gavalda et al., 2009; Gutierrez et al., 2013; Kisiswa et al., 2013; 
McWilliams et al., 2015; O'Keeffe et al., 2008).  The effect of these factors on axon growth is 
transient.  Typically, the neurons begin responding to these factors several days after they 
have started to respond to neurotrophins and the developmental window over which they 
exert their effects is short compared with the extended period over which neurotrophins act.  
The transient influence of the TNFSF/TNFRSF member on axon growth in the developing 
PNS generally coincides with the perinatal period when axons are ramifying extensively in 
their targets. It is therefore likely that the TNFSF plays an important role refining innervation 
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during this critical period of development. 
The enhanced NGF-promoted axon growth phenotype of SCG neurons cultured from 
April-/- mice was replicated by transfecting wild type SCG neurons with siRNA that knock 
down expression of both TWE-PRIL and APRIL, but was not observed in SCG neurons 
transfected with siRNA that selectively knock down either APRIL or TWEAK.  This 
suggests that TWE-PRIL, but neither APRIL nor TWEAK, is responsible for suppressing 
NGF-promoted axon growth. This in turn suggests that the increased growth of SCG nerve 
fiber branches in April-/- embryos in vivo is due to the absence of TWE-PRIL rather than the 
absence of APRIL.  
TWE-PRIL comprises the extracellular ligand-binding domain of APRIL fused to the 
cytoplasmic and transmembrane domains of TWEAK (Kolfschoten et al., 2003; Pradet-
Balade et al., 2002) and binds the same two members of the TNFRSF as APRIL, BCMA and 
TACI.  Several findings suggest that BCMA, rather than TACI, is required for the 
suppression of NGF-promoted axon growth by TWE-PRIL.  First, whereas Bcma mRNA is 
present in developing SCG from E13 onward, Taci mRNA was barely detectable at any age.  
Second, BCMA immunoreactivity was clearly present in cultured neonatal SCG neurons, 
whereas TACI immunoreactivity was barely above background.  Third, transfecting SCG 
with siRNA that knock down BCMA enhanced NGF-promoted axon growth as effectively as 
siRNA knockdown of TWE-PRIL, whereas siRNA directed against TACI had no effect on 
NGF-promoted axon growth. 
Two observations suggest that BCMA and TWE-PRIL modulate axon growth by an 
autocrine mechanism. First, almost all neonatal SCG neurons were labeled by antibodies to 
BCMA and TWE-PRIL/APRIL, suggesting that these neurons co-express BCMA and TWE-
PRIL/APRIL.  Second, all in vitro experiments were carried out on SCG neurons cultured at 
exceptionally low density. As such, the neurons were non-contiguous and were cultured in a 
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relatively large volume of medium. Co-labeling and very low-density culture studies of 
sympathetic and sensory neurons have likewise concluded that several members of the 
TNFSF and TNFRSF families are likely to exert their effects on axon growth by an autocrine 
mechanism.  These include enhanced NGF-promoted sympathetic axon growth by 
GITRL/GITR (O'Keeffe et al., 2008) and CD40L/CD40 (McWilliams et al., 2015) and 
suppressed BDNF-promoted sensory axon growth by LIGHT/HVEM (Gavalda et al., 2009). 
In addition to autocrine signaling, the TNFSF/TNFRSF can also regulate axon growth and 
tissue innervation by a paracrine mechanism, for example, target-derived TNFR1 enhances 
sympathetic axon growth by activating TNF reverse signaling in axons (Kisiswa et al., 2013, 
2017). 
It is likely that autocrine interaction of TWE-PRIL and BCMA suppresses NGF-
promoted axon growth by a BCMA-activated TWE-PRIL-mediated reverse signaling 
mechanism.  First, the enhanced NGF-promoted axon growth phenotype of SCG neurons 
cultured from April-/- mice is completely rescued by transfecting the neurons with a TWE-
PRIL expression plasmid but not by treating the neurons with soluble APRIL. Because the 
expressed TWE-PRIL is able to integrate into the membrane it has the potential to mediate 
reverse signaling. Soluble APRIL, on the other hand, is not membrane integrated and only 
has the potential to activate BCMA-mediated forward signaling. Second, soluble APRIL 
enhances NGF-promoted axon growth of wild type SCG neurons as effectively as deletion of 
April/Twe-pril or siRNA knockdown of TWE-PRIL. The most parsimonious explanation for 
this result is that soluble APRIL competes with endogenous membrane-integrated TWE-
PRIL for binding to endogenous BCMA, and thereby inhibits endogenous BCMA from 
activating TWE-PRIL-mediated reverse signaling.  Furthermore, these experiments also 
control for the efficacy of the soluble APRIL used in the phenotype rescue experiments.  
We showed that enhanced NGF-promoted axon growth from April-/- SCG neurons can 
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also be eliminated by transfecting the neurons with an APRIL expression plasmid. This 
suggests that membrane-integrated APRIL is also able to mediate reverse signaling and can 
substitute for TWE-PRIL in rescuing the phenotype of April-/- SCG neurons in vitro.  
However, siRNA that specifically knocks down APRIL in wild type SCG neurons and leaves 
TWE-PRIL unaffected does not affect NGF-promoted axon growth.  This suggests that 
endogenous APRIL reverse signaling does not normally contribute to the regulation of NGF-
promoted axon growth.  This apparent discrepancy may be because endogenous APRIL may 
be expressed at a much lower level than TWE-PRIL in developing SCG neurons.  Moreover, 
it has been shown in HEK293 cells that APRIL is cleaved in the Golgi apparatus by a furin 
convertase to generate a biologically active secreted protein (Lopez-Fraga et al., 2001). This 
implies that APRIL is not expressed at the cell surface and therefore could not mediate 
reverse signaling.  Because APRIL expression in our transfection experiments is under the 
control of a strong promoter, APRIL may have been expressed at levels that exceed the 
capacity of the Golgi apparatus to process it.  While our data do not support a role of 
endogenous APRIL-mediated reverse signaling in modulating NGF-promoted axon growth in 
SCG neurons, we cannot exclude the possibility that APRIL reverse signaling contributes to 
the regulation of sympathetic axon growth in vivo.  
Contrary to the view that APRIL is produced solely as a secreted ligand (Lopez-Fraga 
et al., 2001), more recent studies have reported APRIL expression at the cell membrane of 
monocyte and macrophage cell lines and primary macrophages (Lee et al., 2010a, 2010b). 
Furthermore, it has been reported that TACI-Fc and an anti-APRIL antibody promote 
expression of pro-inflammatory mediators and inhibit phagocytosis and chemotaxis in the 
THP-1 monocyte cell line, suggesting that these effects are mediated by APRIL reverse 
signaling  (Lee et al., 2010a). APRIL reverse signaling could not, however, be demonstrated 
in primary macrophages (Nys et al., 2013). 
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Several recent studies have reported that reverse signaling by members of the TNFSF 
is physiologically relevant for regulating axon and dendrite growth. TNFR1-activated TNF 
reverse signaling enhances the growth of sympathetic and sensory axons in vitro and plays a 
role in establishing target field innervation in vivo (Kisiswa et al., 2013, 2017; Wheeler et al., 
2014). CD40-activated CD40L reverse signaling enhances sympathetic axon growth in vitro 
and promotes the sympathetic innervation of a subset of tissues in vivo (McWilliams et al., 
2015). CD40L reverse signaling has also been recently shown to exert opposite effects in vivo 
on the growth and complexity of excitatory hippocampal pyramidal neuron dendrites and 
inhibitory striatal medium spiny neuron dendrites (Carriba and Davies, 2017).  
We have shown that modulation of NGF-stimulated ERK activation plays a key role 
in mediating the effects of TWE-PRIL reverse signaling on axon growth.  Likewise, 
modulation of ERK activation is a key step in effecting the influence of TNFR1-activated 
TNF reverse signaling on axon growth (Kisiswa et al, 2013).  However, whereas TNF reverse 
signaling enhances NGF-stimulated ERK activation, TWE-PRIL reverse signaling appears to 
have the opposite effect.  Activation of PKC is a key step in ERK activation by TNF reverse 
signaling, and PKC activation has been shown to mediate the effects of CD40L reverse 
signaling on dendrite growth in the CNS.  However, different PKC isoforms have been 
implicated in mediating the promotion and inhibition of dendrite growth by CD40L reverse 
signaling in different CNS neurons (Carriba and Davies, 2017).  Whether PKC and whether 
distinct PKC isoforms play a role in mediating the axon growth inhibitory effects of TWE-
PRIL reverse signaling are interesting questions for future research as is the potential 
modulation of other signaling pathways that influence axon growth.                                           
In summary, our data suggest that TWE-PRIL reverse signaling is a physiologically 
relevant regulator of NGF-promoted sympathetic axon growth (Fig. 8). Since TWE-PRIL 
reverse signaling has yet to be reported in any system, our study not only shows that TWE-
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PRIL can mediate reverse signaling, but also provides evidence for the first physiological role 
for TWE-PRIL. 
 
 
 
MATERIALS AND METHODS 
Animals  
 This study was conducted on tissues obtained from CD1 wild type mice (Mus 
musculus) and mice with a null mutation in the April gene (gift from Raif Geha, Boston 
Children's Hospital, Harvard Medical School, Cambridge, MA, USA) that were backcrossed 
into a CD1 background.  The April null mice lack half of exon 3 and exons 4 to 6 of the April 
gene which encode 126 amino acids of the extracellular domain (Castigli et al., 2004). As 
such, these mice lack both APRIL and TWE-PRIL. Breeding, housing and genotyping was 
approved by the Cardiff University Ethical Review Board and was performed within the 
guidelines of the Home Office Animals (Scientific Procedures) Act, 1986.   
 
Neuron culture 
SCG were dissected from embryonic and postnatal CD1 mice.  The ganglia were 
trypsinized, and plated at very low density (~ 500 neurons per dish) in poly-
ornithine/laminin-coated 35 mm or 4-well tissue culture dishes (Greiner, Germany) in serum-
free Hams F14 medium (Davies et al., 1993) supplemented with 0.25% Albumax I (Life 
Technologies, UK).   
Neuronal survival was estimated by counting the number of attached neurons within a 
12 X 12 mm grid in the center of each dish 2 hours after plating and again after 24 hours, and 
expressing the 24 hour count as a percentage of the 2 hour count. Analysis of the size and 
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complexity of axon arbors was carried out by labeling the neurons at the end of the 
experiment with the fluorescent vital dye calcein-AM (Life Technologies, UK). For every 
condition in each experiment, images of at least 50 neurons were digitally acquired by 
fluorescence microscopy and analysed to obtain total axon length, number of branch points 
and Sholl profiles (Gutierrez and Davies, 2007).   Statistical analyses were performed using 
one way ANOVA with Bonferroni-Holm post hoc test. Pair-wise comparisons were made 
using Student's t-test.  
For siRNA experiments, dissociated suspensions of SCG neurons were electroporated 
with Silencer Select™ siRNAs (Life Technologies, UK) directed against TWE-PRIL/APRIL, 
APRIL alone, TWEAK alone, BCMA, TACI or with a scrambled control siRNA. Co-
transfection of a GFP expression plasmid allowed identification of the transfected neurons 
and imaging of their processes. 
Recombinant NGF and APRIL were obtained from R&D Systems (Minneapolis, MN, 
USA).  Where indicated, the culture medium was supplemented with the caspase inhibitor 
Boc-D-FMK (Calbiochem, UK) to prevent neuronal apoptosis in the absence of or in low 
concentrations of NGF. Expression plasmids were obtained from OriGene and the truncated 
TWE-PRIL construct was synthesized by Eurofins. 
 
Immunocytochemistry 
The culture medium was gently aspirated and the cultures were washed with PBS at 
37°C. Cells were fixed with either ice-cold methanol (MeOH) for 5 min or freshly-made 4% 
paraformaldehyde (Sigma-Aldrich, UK) in 0.12M Phosphate buffer, pH 7.2 for 12 min. The 
fixative was removed and after washing with PBS, the cultures were blocked for ~1 hour at 
room temperature in 5% BSA containing 0.2% Triton X-100 (Sigma-Aldrich, UK). The 
cultures were then incubated overnight at 4°C with primary antibody in PBS containing 1% 
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BSA (Sigma-Aldrich, UK) and were gently agitated on an orbital shaker.  After extensive 
washing in PBS, the cultures were incubated with fluorophore-conjugated secondary 
antibody (Alexa Fluor 488/546, Thermo, UK) in 1% BSA for 1 hour in the dark at RT. 
Following serial washes in PBS, the nuclei were counterstained with DAPI (1:10,000 
dilution; Life Technologies, UK) for 5 min. The cultures were imaged with either a Zeiss 
Axiovert 200 Inverted Fluorescence microscope or with a Zeiss LSM 710 Confocal Laser 
Scanning Microscope using Zen software (Zeiss, UK). The following primary antibodies 
were used: rabbit polyclonal anti-APRIL (1:300, ab64967, Abcam, UK), rabbit polyclonal 
anti-APRIL (1:300, 19976, Thermo, UK), rat monoclonal anti-APRIL (1:300, ALX-804-141-
C100, Enzo, UK), rabbit polyclonal anti-BCMA (1:300, ab5972, Abcam, UK), rabbit 
polyclonal anti-TWEAK (1:300, ab37170), rabbit polyclonal anti-TACI (1:200, ab79023) 
and mouse monoclonal anti-III tubulin (1:500, MAB1195, R&D Systems, Minneapolis, 
MN, USA). 
 
Analysis of SCG fibers in vivo 
Analysis of sympathetic fiber growth from the SCG was carried out by 
immunolabelling-enabled three-dimensional imaging of solvent-cleared organs (iDISCO) 
(Renier et al., 2014) of E16 April+/+ and April-/- heads. Briefly, the heads were fixed in 4% 
paraformaldehyde for 24 h and serially dehydrated in a series of increasing methanol 
concentrations in water. The samples were then incubated overnight in 66% dichloromethane 
(DCM) / 33% methanol, bleached in chilled 5% H2O2 to reduce tissue auto-fluorescence and 
then serially rehydrated in a series of decreasing methanol concentrations in water.  After 
rehydration, the heads were washed in PBS containing 0.2% Triton X-100 (PTx.2) and were 
incubated in permeabilization solution (PTx.2, 20% DMSO and 0.3M glycine) for 36 h at 
37°C. After permeabilisation, the samples were washed twice in PTx.2 and then incubated in 
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blocking solution (6% donkey serum, 10% DMSO in PTx.2) for 36 h at 37°C. The heads 
were then incubated with rabbit polyclonal anti-tyrosine hydroxylase antibody (1:300, 
AB152, Millipore, UK) in PTwH (0.2% Tween-20 and 10mg/ml heparin in PBS) containing 
5% DMSO and 3% donkey serum for 72 h at 37° C. Following extensive washing in PTwH, 
the samples were incubated with donkey anti-rabbit 647 Alexa Fluor secondary antibody 
(1:300, A-31573, Life Technologies, UK) in PTwH plus 3% donkey serum for 72 h at 37° C. 
After further washing in PTwH, samples were cleared by dehydration in a series of methanol 
concentrations in water followed by 3 h incubation in 66% DCM / 33% methanol. After 
washing in 100% DCM, the samples were placed in dibenzyl ether (DBE) until clear and 
imaged while submerged in DBE.  
The specimens were imaged using a LaVision Light Sheet Ultramicroscope.  5 m 
optical sections were acquired using a Neo high sensitivity CMOS camera.  Captured z-axis 
images were analyzed with Imaris 9 software (Bitplane Scientific Solutions), which allows 
for reconstruction of TH-positive fibers in three dimensions. The Filament Tracer module 
was used to detect fibers within the selected region of interest with semi-manual 
segmentation and the Surface Creation Module allowed for automized three-dimensional 
computerized reconstructions of TH-positive fibers after manual threshold optimization 
(Schindelin et al., 2012). The April-/- data are expressed as a percentage of the mean of 
April+/+ data. All imaging and quantification was performed blind with genotypes determined 
after TH quantification. 
 
RT-qPCR 
The levels of April, Twe-pril, Tweak, Bcma ,Taci, TrkA and p75mRNAs were 
quantified by RT-qPCR in total RNA extracted from dissected SCG relative to a geometric 
mean of mRNAs encoding the house keeping enzymes glyceraldehyde phosphate 
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dehydrogenase (GAPDH) and succinate dehydrogenase (SDHA). Total RNA was extracted 
from dissected tissues with the RNeasy Mini Lipid extraction kit (Qiagen, UK), and 5 l was 
reverse transcribed for 1 h at 45°C using the AffinityScript kit (Agilent, Berkshire, UK) in a 
25 µl reaction according to the manufacturer’s instructions. 2 µl of cDNA was amplified in a 
20 µl reaction volume using Brilliant III ultrafast QPCR master mix reagents (Agilent, 
Berkshire, UK). QPCR products were detected using dual-labelled (FAM/BHQ1) 
hybridization probes specific to each of the cDNAs (MWG/Eurofins, Ebersberg, Germany). 
The PCR primers were: April forward, 5’-CTG TCC TTC CTA GAT AAT G-3’ and reverse, 
5’-CTA GTG ACA CTC TGA CAC-3’; Bcma forward, 5’-TGA CCA GTT CAG TGA AAG 
G-3’ and reverse, 5’-GGG TTC ATC TTC CTC AGC-3’; Tweak forward, 5’-CTT GCT CTT 
CTT TAA CAT CC-3’ and reverse, 5’-GAT AAG TAG GGG CTT TGG-3’; Twe-pril 
forward, 5’-ATT CTC AGC CAC AGC AGC-3’ and reverse, 5’-TTC GCC CCA TCC TTC 
CAG-3’; Taci forward, 5’-CTC AAG GAA ATC CTG TG-3’and reverse, 5’-GAA TTT GCA 
GAA GTC TGT AC-3’; TrkA forward, 5’-CTG TGT CCA TCA CAT CAA-3’ and reverse, 
5’-GAA GGT TGT AGC ACT CAG-3’; p75 forward, 5-ACC AGA GGG AGA GAA ACT-
3’ and reverse, 5’-GCA GGC TAC TGT AGA GGT-3’; Gapdh forward, 5’-GAG AAA CCT 
GCC AAG TAT G-3’ and reverse, 5’-GGA GTT GCT GTT GAA GTC-3’; Sdha forward, 5’-
GGA ACA CTC CAA AAA CAG-3’ and reverse, 5’-CCA CAG CAT CAA ATT CAT-3’. 
Dual-labelled probes were: April, 5’-FAM-CAC CAA ATT CTC CTG AGG CT-BHQ1-3’; 
Bcma, 5’-FAM-CGT ACA CGG TGC TCT GGA TCT TCT T-BHQ1-3’; Tweak, 5’-FAM-
CCA CCA CAA CTA TCC ACC TCA C-BHQ1-3’; Taci, 5’- FAM-CGC TGG CTC CTC 
TGG CTG-BHQ1-3’; TrkA, 5’-FAM-CGC CAG GAC ATC ATT CTC AAG T-BHQ1-3’; 
p75, 5’-FAM-ACA GCG ACA GCG GCA TCT-BHQ1-3’; Gapdh, 5’-FAM-AGA CAA 
CCT GGT CCT CAG TGT-BHQ1-3’; Sdha, 5’-FAM-CCT GCG GCT TTC ACT TCT CT-
BHQ1-3’. The dual-labelled Twe-pril probe (Eurogentec, Southampton, UK) was modified 
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with locked nucleic acids (LNA) at the underlined positions and was; 5’-FAM-CCA GGA 
CAT CAG GAC TCT-BHQ1-3’. Forward and reverse primers were used at a concentration 
of 150 nM each and dual-labelled probes were used at a concentration of 300 nM. PCR was 
performed using the Mx3000P platform (Agilent, UK) using the following conditions:  45 
cycles of 95°C for 11 seconds and 60°C for 35 seconds. Standard curves were generated for 
each cDNA for every real time PCR run, by using serial three-fold dilutions of reverse 
transcribed adult mouse spleen total RNA (AMS Biotechnology, UK). Three to six separate 
dissections were performed for each age. 
 
Immunoblotting 
Whole SCG or SCG neurons cultured at high density in 96-well plates (>5000 cells / 
well) were lysed in ice-cold RIPA lysis buffer supplemented with protease and phosphatase 
inhibitor cocktail mix (Sigma-Aldrich). Insoluble debris was removed by centrifugation. 
Equal quantities of protein were run on pre-cast 4-20% SDS-PAGE gels (BioRad) and were 
transferred to PVDF membranes using a TransBlot Turbo Apparatus (BioRad), which were 
then incubated with blocking solution for 1 h at room temperature (5% non-fat dry milk in 
PBS with 0.1% Tween-20, PBS-T).  After washing with PBS-T the blots were probed 
overnight at 4°C with the following antibodies:  rabbit anti-TH (1:1000, AB152, 
Millipore), rabbit anti-phospho-ERK1/ERK2 (1:1000, ab9101, Cell Signaling Technologies), 
rabbit anti-total ERK1/ERK2 (1:1000, ab9102, Cell Signaling Technologies), rabbit anti-
TrkA (1:500, ab2505, Cell Signaling Technologies) or mouse anti--III tubulin (1:5000, 
MAB1195, R&D). Bound primary antibodies were visualized with HRP-conjugated anti-
mouse or anti-rabbit secondary antibodies  (1:2000, W4021 or W4011, Promega) and 
Immunocruz Luminol reagent (SantaCruz) and Amersham Hyperfilm ECL (GE Life 
Sciences). Densitometry was carried out using Image Studio Lite (Li-cor Biosytems).  The 
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levels of phospho-ERK1 and phospho-ERK2 were normalized to the levels of total ERK1 
and ERK2. 
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Figures 
 
 
 
Figure 1 - Developing SCG neurons express APRIL/TWE-PRIL, TWEAK and BCMA.  
(A) Graphs of the levels of Twe-pril, April, Tweak, Bcma and Taci mRNAs in the SCG of 
E13, E15, E18, P0 and P3 mice relative to the geometric mean of reference mRNAs for 
glyceraldehyde phosphate dehydrogenase and succinate dehydrogenase. Data are expressed 
relative to the levels in adult spleen.  (B) Images of dissociated P0 SCG cultures incubated 
for 16 h in medium containing 0.1 ng/ml NGF and 25 M Boc-D-FMK and triple labeled 
with anti-III tubulin antibody, the nuclear marker DAPI and antibodies that bind either 
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APRIL/TWE-PRIL, BCMA, TWEAK or TACI.  Cultures of wild type SCG neurons double-
labelled with anti-APRIL/TWE-PRIL and anti-BCMA and the no anti-APRIL/TWE-PRIL 
staining controls of cultures established from April-/- mice are shown below these panels. 
Scale bar, 20 m. 
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Figure 2. Increased growth of SCG fibers in E16 April-/- embryos.  (A) Representative 
collapsed Z-stack light sheet fluorescent microscope images of April+/+ and April-/- heads of 
iDISCO preparations stained for TH.  (B) Representative Bitplane Imaris reconstructions of 
light sheet Z-stacks of April+/+ and April-/- heads viewed in the transverse plane.  (C) Scatter 
bar chart of the lengths of the longest SCG fibers measured in Bitplane Imaris reconstructions 
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(mean and individual data points, n = 6 separate embryos of each genotype, * p<0.05, t-test).  
(D) Representative manual tracings of rostral SCG fibers made from Bitplane Imaris 
reconstructions of April+/+ and April-/- heads viewed in the transverse plane. (E) Scatter bar 
chart of the combined lengths of rostral SCG fibers measured in Bitplane Imaris 
reconstructions (mean and individual data points, n = 6 separate embryos of each genotype, 
*** p<0.001, t-test). (F) Representative images of SCG fiber reconstruction using an 
automatic surface rendering programme based on Bitplane Imaris reconstructions of April+/+ 
and April-/- heads viewed in the transverse plane. (G) Scatter bar chart representing the total 
surface volume of rostral SCG fibers (proportional to total fiber length) in reconstructions 
generated by the Imaris Surface Creation module (mean and individual data points, n = 6 
separate embryos of each genotype, *** p<0.001, t-test).  Scale bars, 1mm.   
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Figure 3 - Enhanced NGF-promoted axon growth from cultured April-/- SCG neurons. 
(A) Micrographs of representative calcein-labeled P0 April+/+ and April-/- SCG neurons 
incubated for 16 h in medium containing 0.1 ng/ml NGF and 25 M Boc-D-FMK. Scale bar, 
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100m. (B) Sholl plots of E16, P0, P3 and P5 SCG neurons incubated for 16 h in medium 
containing 0.1 ng/ml NGF and 25 M Boc-D-FMK. Mean ± s.e.m of data of >50 neurons per 
condition. (C) Graphs of total axon length of the arbors of P0 April+/+ and April-/- SCG 
neurons incubated for 16 h in medium containing 25 M Boc-D-FMK and different 
concentrations of NGF. Mean ± s.e.m of data of >50 neurons per condition (*** p<0.001, 
statistical comparison between April+/+ and April-/-). (D) Graph of the survival of P0 April+/+ 
and April-/- SCG neurons incubated for 24 h in medium containing different concentrations of 
NGF.  Mean ± s.e.m of data from 3 separate experiments. 
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Figure 4 - siRNA knockdown of either TWE-PRIL or BCMA, but not APRIL alone, 
enhances NGF-promoted axon growth from SCG neurons. (A) Schematic diagram of the 
intron/exon structure of the April, Tweak, Bcma and Taci genes and the regions of the April 
(blue) and Tweak (red) genes from which the primary Twe-pril transcript is generated.  The 
fusion sites of April and Tweak to generate the primary Twe-pril transcript are indicated by 
vertical red lines.  Exons are numbered and indicated by boxes.  The sites to which sets of 
siRNA bind are indicated by arrows. (B) Micrographs of representative P0 SCG neurons that 
were co-transfected with a GFP expression plasmid and either control scrambled siRNA, 
BCMA siRNA, APRIL-specific siRNA or siRNA that knock down TWE-PRIL and APRIL.  
The neurons were incubated for 16 h after transfection in medium containing 1 ng/ml NGF 
and 25 M Boc-D-FMK. Scale bar, 100m. (C) Bar chart of total axon length of the arbors 
of P0 SCG neurons transfected with a GFP expression plasmid plus: control scrambled 
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siRNA, siRNA that knock down TWE-PRIL plus APRIL, siRNA that selectively knock 
down either APRIL, TWEAK, BCMA or TACI without targeting TWE-PRIL expression, 
siRNA that knock down APRIL and TWEAK and siRNA that knock down TWE-PRIL plus 
APRIL and TWEAK. Mean ± s.e.m of data of >50 neurons per condition (***, p<0.001, 
comparison with control siRNA, ANOVA). 
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Figure 5 - Rescue of in vitro phenotype of April-/- SCG neurons transfected with either 
full-length TWE-PRIL or full-length APRIL expression plasmids but not by 
transfection of truncated TWE-PRIL, TWEAK or BCMA expression plasmids or 
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treatment with soluble APRIL. (A) Images of representative calcein-labeled P0 April-/- 
SCG neurons incubated for 16 h in medium containing 0.1 ng/ml NGF and 25 M Boc-D-
FMK with and without 100 ng/ml soluble recombinant APRIL. (B) Images of representative 
P0 SCG neurons of April+/+ and April-/- mice that were co-transfected with a GFP expression 
plasmid plus either an empty control plasmid or plasmids that express either full-length (FL) 
TWE-PRIL or FL-APRIL. The neurons were incubated for 16 h after transfection in medium 
containing 1 ng/ml NGF and 25 M Boc-D-FMK. Scale bar, 100m. (C) Bar chart of total 
axon length of SCG neurons from April+/+ and April-/- mice that were co-transfected with a 
GFP expression plasmid plus either an empty control plasmid or plasmids that express either 
full-length APRIL, full-length TWE-PRIL, truncated TWE-PRIL that lacks a cytoplasmic 
domain (TWE-PRIL), BCMA and TWEAK. Mean ± s.e.m of data of >50 neurons per 
condition (***, p<0.001, ANOVA). 
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 Figure 6 - Soluble APRIL enhances NGF-promoted axon growth from SCG neurons. 
(A) Images of representative calcein-labeled P0 April+/+ SCG neurons incubated for 16 h in 
medium containing 0.1 ng/ml NGF and 25 M Boc-D-FMK with and without 100 ng/ml 
soluble recombinant APRIL. Scale bar, 100m. (B) Bar charts of total length of axons in the 
arbors of P0 SCG neurons grown for 16 h in medium containing 0.1 ng/ml NGF, 25 M Boc-
D-FMK and different concentrations of APRIL. Mean ± s.e.m of data of >50 neurons per 
condition (*** p<0.001, statistical comparison with no APRIL). (C) Sholl plots of E16, P0, 
P3 and P5 April+/+ SCG neurons incubated for 16 h in medium containing 0.1 ng/ml NGF and 
25 M Boc-D-FMK, with and without 100 ng/ml APRIL. (D) Graphs of total axon length in 
the arbors of P0 April+/+ SCG neurons incubated for 16 h in medium containing Boc-D-FMK 
and different concentrations of NGF, with and without 100 ng/ml APRIL. Mean ± s.e.m of 
data of >50 neurons per condition (* p< 0.05, ** p<0.01, *** p<0.001, statistical comparison 
of neurons grown with and without APRIL). (E) Graph of the survival of P0 SCG neurons 
incubated for 24 h in medium containing different concentrations of NGF with and without 
100 ng/ml APRIL.  Mean ± s.e.m of data from 3 separate experiments.  
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Figure 7 – NGF-stimulated ERK activation is enhanced in April-/- neurons and 
inhibition of ERK activation eliminates the differences in axon growth between April-/- 
and April+/+ neurons. (A) Representative western blots probed for phospho-ERK1/ERK2, 
total ERK1/ERK2, TrkA and -III tubulin of lysates of P0 SCG neurons of April-/- and 
April+/+ mice that had been incubated with 25 M Boc-D-FMK for 12 h before either 30 min 
treatment with NGF (0.1 or 10 ng/ml) or no treatment. (B) Densitometry of 3 separate 
experiments (mean ± sem of phospho-ERK1/ERK2 relative to total ERK1/ERK2). (C) Bar 
charts of total length of axons in the arbors of P0 SCG neurons of April-/- and April+/+ mice 
that were plated in medium containing either 10 M U0126 or 10 M U0124 and were 
treated with either 0.1 ng/ml NGF or 0.1 ng/ml NGF plus 100ng/ml APRIL an hour after 
plating. Axon arbors were imaged 16 hours later. Mean ± s.e.m of data of >50 neurons per 
condition (*** p<0.001, statistical comparison indicated). 
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Figure 8 - Schematic outline of the suppression of NGF-promoted sympathetic axon 
growth by TWE-PRIL reverse signaling. (A) Model illustrating suppression of NGF-
promoted axon growth by BCMA-activated TWE-PRIL reverse signaling in developing SCG 
neurons (represented by the semi-circle).  Arrows indicate the ERK-mediated intracellular 
signaling that links TWE-PRIL reverse signaling to axon growth.  (B, C, D) Summary of the 
main experimental manipulations that underlie this model. (B) Selective knock down of 
TWE-PRIL by siRNA or the absence of TWE-PRIL in April-/- mice removes the suppression 
signaling, resulting in enhanced NGF-promoted axon growth.  (C) Knock down of BCMA by 
siRNA removes the activator of TWE-PRIL reverse signaling, resulting in removal of 
suppression signaling and enhanced NGF-promoted axon growth. (D) Soluble APRIL 
competes with endogenous TWE-PRIL for binding to BCMA, resulting in reduced or absent 
activation of TWE-PRIL reverse signaling, removal of suppression signaling and enhanced 
NGF-promoted axon growth. 
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Figure S1.  TH levels are not significantly different between the SCG of April+/+ and
April-/- mice. (A) Western blot of TH and βIII-tubulin in SCG dissected from 3 separate 
litters of April+/+ and 3 separate litters of April-/- newborn mice (6 ganglia per litter). (B) 
Quantification by densitometry of the ratio of TH to βIII-tubulin levels in the Western blots 
shown in A normalized to the ratio in April+/+ mice.
Development: doi:10.1242/dev.165936: Supplementary information
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Figure S2. siRNAs eliminate immunoreactivity for the proteins to which they are 
directed.   Representative images of P0 SCG neurons that were co-transfected with a GFP 
expression plasmid to indicate which neurons were transfected (green and arrows) and the 
siRNAs indicated.  The neurons were subsequently stained for expression of the indicated 
proteins (red) 16 h after incubation in medium containing 1 ng/ml NGF and 25 µM Boc-D-
FMK. Scale bar, 100 µm.
Development: doi:10.1242/dev.165936: Supplementary information
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Figure S3. Specificity of siRNA knockdown.   Representative images of P0 SCG neurons 
that were co-transfected with a GFP expression plasmid to indicate which neurons were 
transfected (green and arrows) and the siRNAs indicated.  The neurons were subsequently 
stained for expression of the indicated proteins (red) 16 h after incubation in medium
containing 1 ng/ml NGF and 25 µM Boc-D-FMK. Scale bar, 100 µm. 
Development: doi:10.1242/dev.165936: Supplementary information
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Figure S4. Deletion of April does not significantly affect expression of mRNAs encoding 
NGF receptors in SCG.  Bar charts of the levels of TrkA mRNA  (A) and p75 mRNA (B) 
relative to the geometric mean of Gapdh and Sdha mRNA in SCG dissected from 4 separate 
litters of April+/+ and 4 separate litters of April-/- mice at 16 days gestation (6 or more ganglia 
per litter).  
Development: doi:10.1242/dev.165936: Supplementary information
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